Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 660

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow Transplantation

Open access
Brissot, Eolia, Labopin, Myriam, Baron, Frédéric, Bazarbachi, Ali, Bug, Gesine, Ciceri, Fabio, Esteve, Jordi, Giebel, Sebastian, Gilleece, Maria H., Gorin, Norbert-Claude, Lanza, Francesco, Peric, Zinaida, Ruggeri, Annalisa, Sanz, Jaime, Savani, Bipin N., Schmid, Christoph, Shouval, Roni, Spyridonidis, Alexandros, Versluis, Jurjen, Nagler, Arnon, Mohty, Mohamad · 2021 · Bone Marrow Transplantation

Abstract

Severe acute respiratory syndrome coronavirus-2 (SARSCoV-2) is the novel coronavirus first detected in Wuhan, China. It causes an infection named coronavirus disease 2019 (COVID-19), and is now spreading worldwide. Currently, there are no approved treatment options in Europe and there is no available vaccine. Reports from China, Europe, and USA suggest a high mortality rate and stretched intensive care unit (ICU) capacity [1–3]. It has been found that the main risk factors for death are obesity, hypertension, diabetes, male gender, and older age. Moreover, Liang et al. reported that 1% of COVID-19 patients had a history of cancer, higher than that of the overall Chinese population (0.29%), with lung cancer being the most frequently found. Moreover, patients with cancer seemed to have a higher risk of severe events (ICU admission, need of assisted ventilation, death), reaching 39% versus 8% in those not suffering from a neoplasia [4]. Their study suggests that hospital admission and recurrent outpatient visits, inherent to cancer patients’ management, are potential risk factors for SARS-CoV-2 infection. Another aspect which may probably be even more relevant in cancer patients is their inability to receive the necessary care in time, under the changed scenario of a viral pandemic management. Scarce data are available on patients with hematological malignancies. Although some recommendations for

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41409-020-0970-x

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

See all 660

Metadata

Authors
Brissot, E., Labopin, M., Baron, F., Bazarbachi, A., Bug, G., Ciceri, F., Esteve, J., Giebel, S., Gilleece, M. H., Gorin, N.-C., Lanza, F., Peric, Z., Ruggeri, A., Sanz, J., Savani, B. N., Schmid, C., Shouval, R., Spyridonidis, A., Versluis, J., Nagler, A., & Mohty, M.
Venue
Bone Marrow Transplantation
Published
2020-06-11
Volume
56
Issue
3
Pages
532-535
ISSN
  • 0268-3369 (ISSN-L)
  • 1476-5365
OpenAlex
W3034225365
Cited by
660
References
16
FWCI
4.97
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow Transplantation. https://app.cochat.ai/papers/10.1038/s41409-020-0970-x
The paper
Brissot, E., Labopin, M., Baron, F., Bazarbachi, A., Bug, G., Ciceri, F., Esteve, J., Giebel, S., Gilleece, M. H., Gorin, N.-C., Lanza, F., Peric, Z., Ruggeri, A., Sanz, J., Savani, B. N., Schmid, C., Shouval, R., Spyridonidis, A., Versluis, J., . . . Mohty, M. (2021). Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow Transplantation. Bone Marrow Transplantation. https://doi.org/10.1038/s41409-020-0970-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.